Mental Health Clinics in Camarillo, CA Accepting Medicare
72 Mental Health Clinics found. Showing 1 - 20
 Healingmd Inc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 601 E Daily Dr Ste 228, Camarillo, CA 93010 Phone: 805-914-0637 |
Mission Oaks Counseling And Wellness Center, Inc. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1100 Flynn Rd, Suite 201, Camarillo, CA 93012 Phone: 805-482-7724 Fax: 805-618-6250 |
Jennifer Miles Therapy Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 360 Mobil Ave Ste A&b, Camarillo, CA 93010 Phone: 805-980-8865 |
Ashley Ribeiro Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1601 Carmen Dr Ste 201b, Camarillo, CA 93010 Phone: 805-618-6697 |
Lorna M. Barte, M.d. And Associates A Behavioral Health Mgmt Group Inc Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1601 Carmen Dr, Suite 106, Camarillo, CA 93010 Phone: 805-389-8111 Fax: 805-389-8188 |
Addison Behavioral Resources, Inc. Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1000 Paseo Camarillo Ste 235, Camarillo, CA 93010 Phone: 888-383-5566 Fax: 888-659-0031 |
Casa Pacifica Centers For Children And Families Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 751 E. Daily Drive, Suite 320, Camarillo, CA 93010 Phone: 805-366-4040 Fax: 805-987-7237 |
Michelle Williams Marriage & Family Therapy, Inc Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 360 Mobil Ave Ste 218b, Camarillo, CA 93010 Phone: 805-990-9533 |
Vcbh - North Oxnard Adult Mental Health Md Satellite Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1756 S Lewis Rd, Camarillo, CA 93012 Phone: 805-981-5478 |
Elevate Psychological Group Inc Psychologist Medicare: Not Enrolled in Medicare Practice Location: 80 Wood Rd Ste 306, Camarillo, CA 93010 Phone: 805-244-6919 |
Doc Martin Psychological Services, Inc. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1317 Del Norte Rd Ste 200, Camarillo, CA 93010 Phone: 805-775-6506 |
Crystal Cummings Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 190 Townsite Promenade, Camarillo, CA 93010 Phone: 805-312-0777 |
Aspira Foster & Family Services - Ventura Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 3601 Calle Tecate Ste 201, Camarillo, CA 93012 Phone: 805-289-0120 Fax: 805-289-0130 |
Integrated Therapy Services Inc. Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 150 Valley Vista Dr, Camarillo, CA 93010 Phone: 805-484-1671 Fax: 805-987-0667 |
Casa Pacifica Centers For Children And Families Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1722 South Lewis Rd, Camarillo, CA 93012 Phone: 805-445-7800 |
K And E Therapy Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 360 Mobil Ave Ste 102a, Camarillo, CA 93010 Phone: 661-903-2591 |
Hayden Consultation Services, Inc. Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1000 Paseo Camarillo, Ste. 114, Camarillo, CA 93010 Phone: 805-701-1254 Fax: 805-445-2926 |
The New Beginnings Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 155 Granada St Ste N, Camarillo, CA 93010 Phone: 805-987-3162 Fax: 805-715-4483 |
Neurological Diagnosis And Therapeutics Ltd Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 316 El Tuaca Ct, Camarillo, CA 93010 Phone: 805-652-5469 Fax: 805-641-1706 |
Anything Is Possible Foundation Counselor Medicare: Not Enrolled in Medicare Practice Location: 409 Calle San Pablo Ste 108, Camarillo, CA 93012 Phone: 818-943-0196 |
News Archive
Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
Researchers precisely describe effects of frequent genetic mutation in congenital hyperinsulinism
Diabetes is characterized by a deficiency of insulin. The opposite is the case in congenital hyperinsulinism: patients produce the hormone too frequently and in excessive quantities, even if they haven't eaten any carbohydrates.
IV ibuprofen effective in reducing fever in hospitalized patients
Cumberland Pharmaceuticals Inc. today announced the publication of data affirming the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults. Published in the peer-reviewed journal Critical Care, the study showed that IV ibuprofen was significantly more effective at reducing fever in hospitalized patients than placebo.
Independent Safety Monitoring Board recommends Vical's Allovectin-7 Phase 3 trial to continue as per protocol
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fifth scheduled safety analysis and recommended that the trial continue per the protocol.
NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
› Verified 6 days ago